Clearance of Pneumocystis carinii in Mice Is Dependent on B Cells But Not on P. carinii-Specific Antibody 1

Both CD4+ T cells and B cells are critical for defense against Pneumocystis carinii infection; however, the mechanism by which B cells mediate protection is unknown. We show that P. carinii-specific IgM is not sufficient to mediate clearance of P. carinii from the lungs since CD40-deficient mice produced normal levels of specific IgM, but were unable to clear the organisms. Using chimeric mice in which the B cells were deficient in CD40 (CD40KO chimeras) we found that clearance of P. carinii infection is delayed compared with wild-type controls. These CD40KO chimeric mice produced normal levels of P. carinii-specific IgM, but did not produce class-switched IgG or IgA. Similarly, clearance of P. carinii was delayed in mice deficient in FcγRI and III (FcγRKO), indicating that P. carinii-specific IgG partially mediates opsonization and clearance of P. carinii. Opsonization of organisms by complement did not compensate for the lack of specific IgG or FcγR, since C3-deficient and C3-depleted FcγRKO mice were still able to clear P. carinii. Finally, μMT and CD40KO chimeric mice had reduced numbers of activated CD4+ T cells in the lungs and lymph nodes compared with wild-type mice, suggesting that B cells are important for activation of T cells in response to P. carinii. Together these data indicate that P. carinii-specific IgG plays an important, but not critical, role in defense against P. carinii. Moreover, these data suggest that B cells also mediate host defense against P. carinii by facilitating CD4+ T cell activation or expansion.

[1]  Arturo Casadevall,et al.  CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. , 2002, Immunity.

[2]  C. Haidaris,et al.  Passive Intranasal Monoclonal Antibody Prophylaxis against Murine Pneumocystis carinii Pneumonia , 2002, Infection and Immunity.

[3]  J. Cyster,et al.  Splenic T Zone Development Is B Cell Dependent , 2001, The Journal of experimental medicine.

[4]  Y. Ron,et al.  Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. , 2001, International immunology.

[5]  J. Shellito,et al.  CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. , 2001, The Journal of clinical investigation.

[6]  J. Standing,et al.  Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii. , 2001, American journal of respiratory cell and molecular biology.

[7]  R. Zinkernagel,et al.  IgA production without μ or δ chain expression in developing B cells , 2001, Nature Immunology.

[8]  S. Swain,et al.  Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.

[9]  J. Volanakis,et al.  Complement-Dependent Acute-Phase Expression of C-Reactive Protein and Serum Amyloid P-Component1 , 2000, The Journal of Immunology.

[10]  M. Shlomchik,et al.  Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy. , 2000, Comparative medicine.

[11]  A. Limper,et al.  Alveolar macrophage interactions with Pneumocystis carinii. , 1999, The Journal of laboratory and clinical medicine.

[12]  H. Ochs,et al.  Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. , 1999, The Journal of pediatrics.

[13]  M. Lepore,et al.  Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia. , 1998, The Journal of allergy and clinical immunology.

[14]  S. Kaufmann,et al.  Activated Pulmonary Macrophages Are Insufficient for Resistance against Pneumocystis carinii , 1998, Infection and Immunity.

[15]  R. Flavell,et al.  CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.

[16]  B. Garvy,et al.  CONTENT ALERTS , 1997 .

[17]  A. Fischer,et al.  Clinical spectrum of X-linked hyper-IgM syndrome. , 1997, The Journal of pediatrics.

[18]  X. Qin,et al.  Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. , 1997, The Journal of clinical investigation.

[19]  J. Standing,et al.  The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. , 1997, The Journal of clinical investigation.

[20]  P. Kvale,et al.  Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. , 1997, American journal of respiratory and critical care medicine.

[21]  B. Garvy,et al.  Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia , 1996 .

[22]  H. Marcotte,et al.  Pneumocystis carinii infection in transgenic B cell-deficient mice. , 1996, The Journal of infectious diseases.

[23]  J. Sun,et al.  Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. , 1996, Immunity.

[24]  D. Gray,et al.  CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.

[25]  R. Flavell,et al.  Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.

[26]  R. Flavell,et al.  Rapid induction of a novel costimulatory activity on B cells by CD40 ligand , 1995, Current Biology.

[27]  A. Harmsen,et al.  CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. , 1995, Journal of immunology.

[28]  F. Gigliotti,et al.  Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice , 1995, Infection and immunity.

[29]  J. Standing,et al.  Pneumocystis carinii glycoprotein A binds macrophage mannose receptors , 1995, Infection and immunity.

[30]  C. Janeway,et al.  Induction of B cell costimulatory function by recombinant murine CD40 ligand , 1994, European journal of immunology.

[31]  S. Goodwin Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus‐Infected Infants and Children , 1993, Pharmacotherapy.

[32]  J. Standing,et al.  Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. , 1993, Journal of immunology.

[33]  J. Shellito,et al.  Host defenses against Pneumocystis carinii in mice selectively depleted of CD4+ lymphocytes. , 1993, Chest.

[34]  C. Sidman,et al.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. , 1992, The Journal of clinical investigation.

[35]  A. Harmsen,et al.  T cells are not sufficient for resistance to Pneumocystis carinii pneumonia in mice. , 1991, The Journal of protozoology.

[36]  D. Williams,et al.  Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor , 1991, Nature.

[37]  S. J. Hayes,et al.  Geosmin As an Odorous Metabolite In Cultures of A Free‐Living Amoeba, Vannella Species (Gymnamoebia, Vannellidae) , 1991 .

[38]  H. Rugo,et al.  Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. , 1990, International immunology.

[39]  A. Harmsen,et al.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice , 1990, The Journal of experimental medicine.

[40]  W. Hughes,et al.  Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. , 1988, The Journal of clinical investigation.

[41]  J. Sprent,et al.  T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. , 1987, Journal of immunology.

[42]  C. Janeway,et al.  The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. , 1987, Journal of immunology.

[43]  D. Gajdusek Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants. , 1957, Pediatrics.